Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaspar Broch

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|June 23, 2025
The N-6 methyladenosine dynamics in STEMI and the effect of IL-6 inhibition - a hypothesis generating sub-study of the ASSAIL-MI trialTuva B Dahl, Ana Quiles-Jiménez, Kaspar Broch, et al.
Frontiers in Immunology|January 10, 2022
The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart FailureMargrethe Flesvig Holt, Annika E Michelsen, Negar Shahini, et al.
International Journal of Molecular Sciences|August 29, 2024
Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial InfarctionFredric A Holme, Camilla Huse, Xiang Yi Kong, et al.
International Journal of Cardiology|January 25, 2024
Diagnostics, treatment and outcomes of cardiac sarcoidosis in a Norwegian cohortAlessandro De Bortoli, Ingvild Nordøy, James Patrick Connelly, et al.
ESC Heart Failure|January 25, 2020
Low fibre intake is associated with gut microbiota alterations in chronic heart failureCristiane C K Mayerhofer, Martin Kummen, Kristian Holm, et al.
American Journal of Respiratory and Critical Care Medicine|May 3, 2021
Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled TrialGunn Marit Traaen, Lars Aakerøy, Tove-Elizabeth Hunt, et al.
International Journal of Cardiology|July 3, 2018
Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarctionOla Kleveland, Thor Ueland, Gabor Kunszt, et al.
JACC. Advances|June 26, 2025
Hepatocyte Growth Factor: A Marker of Cardiac Function, Mortality, and Disease Subtype in Cardiac AmyloidosisMargrethe Flesvig Holt, Annika E Michelsen, August Flø, et al.
JACC. Heart Failure|June 27, 2024
Randomized Trial of Cholesterol Lowering With Evolocumab for Cardiac Allograft Vasculopathy in Heart Transplant RecipientsKaspar Broch, Karl B Lemström, Finn Gustafsson, et al.
JACC. Heart Failure|April 1, 2017
Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart FailureStåle H Nymo, Pål Aukrust, John Kjekshus, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|June 23, 2025
The N-6 methyladenosine dynamics in STEMI and the effect of IL-6 inhibition - a hypothesis generating sub-study of the ASSAIL-MI trialTuva B Dahl, Ana Quiles-Jiménez, Kaspar Broch, et al.
Frontiers in Immunology|January 10, 2022
The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart FailureMargrethe Flesvig Holt, Annika E Michelsen, Negar Shahini, et al.
International Journal of Molecular Sciences|August 29, 2024
Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial InfarctionFredric A Holme, Camilla Huse, Xiang Yi Kong, et al.
International Journal of Cardiology|January 25, 2024
Diagnostics, treatment and outcomes of cardiac sarcoidosis in a Norwegian cohortAlessandro De Bortoli, Ingvild Nordøy, James Patrick Connelly, et al.
ESC Heart Failure|January 25, 2020
Low fibre intake is associated with gut microbiota alterations in chronic heart failureCristiane C K Mayerhofer, Martin Kummen, Kristian Holm, et al.
American Journal of Respiratory and Critical Care Medicine|May 3, 2021
Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled TrialGunn Marit Traaen, Lars Aakerøy, Tove-Elizabeth Hunt, et al.
International Journal of Cardiology|July 3, 2018
Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarctionOla Kleveland, Thor Ueland, Gabor Kunszt, et al.
JACC. Advances|June 26, 2025
Hepatocyte Growth Factor: A Marker of Cardiac Function, Mortality, and Disease Subtype in Cardiac AmyloidosisMargrethe Flesvig Holt, Annika E Michelsen, August Flø, et al.
JACC. Heart Failure|June 27, 2024
Randomized Trial of Cholesterol Lowering With Evolocumab for Cardiac Allograft Vasculopathy in Heart Transplant RecipientsKaspar Broch, Karl B Lemström, Finn Gustafsson, et al.
JACC. Heart Failure|April 1, 2017
Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart FailureStåle H Nymo, Pål Aukrust, John Kjekshus, et al.
Pageof 10